| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_91a1f2736ee8b9a3535d2a29196834a4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6617970081e080d9214d1e97256af2dd |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-986 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-1217
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-1228
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-577
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-40 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-573 |
| filingDate |
2021-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b797aaabd65eed3e60f6197de7a5c58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f508b9759c6b786c543a519cb3210be
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21da1073b77d648e279ced26166829ae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_600ba4d8118a2f109a20657d231f1bc2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1bb8ac91bddcb19e0a14cd939f810b17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44224811bb03efb59908cba51db64d8e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a5e4ac20daa2f9f2e9c6038f5ce8e7c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_75159f9a3a9fe1e73ffcd2de789a7a2d |
| publicationDate |
2022-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2022166353-A1 |
| titleOfInvention |
Anti-imp type carbapenemase hybridoma cell strain, monoclonal antibody and use |
| abstract |
Provided is an anti-IMP type carbapenemase hybridoma cell strain. The hybridoma cell strain capable of stably secreting an anti-IMP type carbapenemase antibody and a variable region sequence thereof are obtained by means of screening a mouse hybridoma monoclonal antibody and cloning an Ig variable region gene by means of an RT-PCR method, and the antibody binding specificity is identified by means of an ELISA method; the antibody can be used for detecting IMP type carbapenemase, the titer reaches 1:640000 or more, and same can be prepared into an in-vitro diagnostic kit or microfluidic chip for early typing of drug-resistant strains, guiding medication and assisting clinical infection control and treatment. |
| priorityDate |
2021-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |